Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

By C. J. Hu, Li Zhang, Santosh Aryal, C. Cheung, Ronnie H. Fang, Liangfang Zhang. Proceedings of the National Academy of Sciences of the United States of America, 2011

2,150 citations recorded by the source corpus.

Subfields: Biomaterials, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/35566ca9d1c34cca9a0227200bbadd15bce1deaa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. N. Bertrand
2. Xiaoyang Xu
3. O. Farokhzad
4. A. Kabanov
5. Xueqing Zhang
6. Richa Gupta
7. S. Mitragotri

In Molecular Biology

1. N. Bertrand
2. Xiaoyang Xu
3. O. Farokhzad
4. Yan Luo
5. Ben Wang
6. A. Kabanov
7. Eric M. Pridgen
8. Xueqing Zhang

Citations in the corpus

• Exosome Theranostics: Biology and Translational Medicine (2018, background): “developed a top-down approach to disguise poly(lactic-co-glycolic acid) (PLGA) nanoparticles with natural erythrocyte membranes [166].”
• Smart nanoparticles for cancer therapy (2023, methodology): “66,67 The common method for the preparation of CMCNPs is the isolation of plasma membrane from different cell sources and incorporation of core nanoparticles into membrane vesicles.”
• Exosomes as Drug Delivery Vehicles for Parkinson’s Disease Therapy (2015, methodology): “The similar methodology was applied to polymer nanoparticles that were covered with erythrocytes membranes [40].”
• The blood–brain barrier: Structure, regulation and drug delivery (2023, methodology): “353 Since then, in addition to membrane-enabled technology, alternative strategies including biomacromolecule-enabled strategy, 354 exosome-mediated carrier, 355 virus-inspired synthesis, 356 extracellular vesicles bionic method, 357 and bacteria bionic strategy 358 have been adopted in preparation…”
• Interactions of nanomaterials and biological systems: implications to personalized nanomedicine (2012, background): “For example, Zhang and colleagues recently proposed red blood cell (RBC) membrane-coated nanoparticles to evade the immune system and exhibit longer retention time in the blood [9].”
• Nanomedicine in cancer therapy (2023, background): “16 RBC membrane-coated nanoparticles (RBC-NPs) exhibit superior circulation half-life, increased tumor accumulation via the EPR effect, and improved therapeutic index of encapsulated drugs as compared to control nanoparticles or free drugs.”